New hope for chemo patients: drug combo aims to stop nausea before it starts
NCT ID NCT07482891
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a combination of two drugs (fosrolapitant and palonosetron) can prevent nausea and vomiting in people receiving strong chemotherapy for the first time. About 200 adults with solid tumors will be enrolled. The goal is to see if this treatment helps patients feel better during and after chemo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shanghai Sixth People's Hospital
RECRUITINGShanghai, Shanghai Municipality, 200233, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ear acupressure: a new weapon against chemotherapy side effects?
- Can a Custom-Made immune cell vaccine turn the tide against solid tumors?
- Can a new tracer light up tumors better than standard PET scans?
- Personalized weight loss coaching could help cancer survivors shed pounds
- Healthy volunteers needed to test new version of cancer drug
- New PET tracer aims to light up tumors, but trial stalls